{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:43:47Z","timestamp":1759041827291,"version":"3.38.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"DOI":"10.7759\/cureus.80589","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:21:56Z","timestamp":1741998116000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and Safety of Recombinant Human Soluble Thrombomodulin in Patients With Sepsis-Induced Disseminated Intravascular Coagulation After Emergency Surgery"],"prefix":"10.7759","author":[{"given":"Keiji","family":"Nagata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2004.02.015","article-title":"Disseminated intravascular coagulation","volume":"344","author":"Wada H","year":"2004","unstructured":"Wada H. Disseminated intravascular coagulation. Clin Chim Acta. 2004, 344:13-21. 10.1016\/j.cccn.2004.02.015","journal-title":"Clin Chim Acta"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181c9e31d","article-title":"Microvascular thrombosis and multiple organ dysfunction syndrome","volume":"38","author":"Gando S","year":"2010","unstructured":"Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 2010, 38:S35-42. 10.1097\/CCM.0b013e3181c9e31d","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0352","article-title":"Nationwide trends of severe sepsis in the 21st century (2000-2007)","volume":"140","author":"Kumar G","year":"2011","unstructured":"Kumar G, Kumar N, Taneja A, et al.. Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest. 2011, 140:1223-31. 10.1378\/chest.11-0352","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-008-8203-z","article-title":"Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry","volume":"37","author":"Beale R","year":"2009","unstructured":"Beale R, Reinhart K, Brunkhorst FM, et al.. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009, 37:222-32. 10.1007\/s15010-008-8203-z","journal-title":"Infection"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study","volume":"273","author":"Rangel-Frausto MS","year":"1995","unstructured":"Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995, 273:117-23. 10.1001\/jama.1995.03520260039030","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.04.025","article-title":"Role of disseminated intravascular coagulation in severe sepsis","volume":"178","author":"Gando S","year":"2019","unstructured":"Gando S, Shiraishi A, Yamakawa K, et al.. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res. 2019, 178:182-8. 10.1016\/j.thromres.2019.04.025","journal-title":"Thromb Res"},{"key":"ref7","article-title":"Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma","volume":"100","author":"Kushimoto S","year":"2008","unstructured":"Kushimoto S, Gando S, Saitoh D, et al.. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma. Thromb Haemost. 2008, 100:1099-105.","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2021.106083","article-title":"Postoperative sepsis after colorectal surgery: a prospective single-center observational study and review of the literature","volume":"17","author":"Mulita F","year":"2022","unstructured":"Mulita F, Liolis E, Akinosoglou K, et al.. Postoperative sepsis after colorectal surgery: a prospective single-center observational study and review of the literature. Prz Gastroenterol. 2022, 17:47-51. 10.5114\/pg.2021.106083","journal-title":"Prz Gastroenterol"},{"key":"ref9","article-title":"Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation","volume":"82","author":"Maruyama I","year":"1999","unstructured":"Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thromb Haemost. 1999, 82:718-21.","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial","volume":"5","author":"Saito H","year":"2007","unstructured":"Saito H, Maruyama I, Shimazaki S, et al.. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007, 5:31-41. 10.1111\/j.1538-7836.2006.02267.x","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04319.x","article-title":"Thrombomodulin: protectorate god of the vasculature in thrombosis and inflammation","volume":"9","author":"Ito T","year":"2011","unstructured":"Ito T, Maruyama I. Thrombomodulin: protectorate god of the vasculature in thrombosis and inflammation. J Thromb Haemost. 2011, 9:168-73. 10.1111\/j.1538-7836.2011.04319.x","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi CS","year":"2008","unstructured":"Shi CS, Shi GY, Hsiao HM, et al.. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood. 2008, 112:3661-70. 10.1182\/blood-2008-03-142760","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama K","year":"2005","unstructured":"Abeyama K, Stern DM, Ito Y, et al.. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005, 115:1267-74. 10.1172\/JCI22782","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.12.033","article-title":"Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy","volume":"133","author":"Asakura H","year":"2014","unstructured":"Asakura H, Takahashi H, Tsuji H, et al.. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy. Thromb Res. 2014, 133:364-70. 10.1016\/j.thromres.2013.12.033","journal-title":"Thromb Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000202209.42491.38","article-title":"A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria","volume":"34","author":"Gando S","year":"2006","unstructured":"Gando S, Iba T, Eguchi Y, et al.. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006, 34:625-31. 10.1097\/01.ccm.0000202209.42491.38","journal-title":"Crit Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198608000-00027","article-title":"APACHE II--a severity of disease classification system","volume":"14","author":"LeGall JR","year":"1986","unstructured":"LeGall JR, Loirat P, Alp\u00e9rovitch A. APACHE II--a severity of disease classification system. Crit Care Med. 1986, 14:754-5. 10.1097\/00003246-198608000-00027","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters R","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010, 138:1093-100. 10.1378\/chest.10-0134","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2023.05.009","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation -- a meta-analysis","volume":"226","author":"Kato H","year":"2023","unstructured":"Kato H, Hagihara M, Asai N, et al.. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation -- a meta-analysis. Thromb Res. 2023, 226:165-72. 10.1016\/j.thromres.2023.05.009","journal-title":"Thromb Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5414\/CP204362","article-title":"Bleeding events associated with recombinant human soluble thrombomodulin, classified according to renal function, in sepsis-induced disseminated intravascular coagulation","volume":"61","author":"Onoda T","year":"2023","unstructured":"Onoda T, Aoyama K, Suzuki M, Matsumoto T, Tanaka H, Ishii T. Bleeding events associated with recombinant human soluble thrombomodulin, classified according to renal function, in sepsis-induced disseminated intravascular coagulation. Int J Clin Pharmacol Ther. 2023, 61:297-305. 10.5414\/CP204362","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-11-201306040-00007","article-title":"Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline","volume":"158","author":"Stevens PE","year":"2013","unstructured":"Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013, 158:825-30. 10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1676345","article-title":"Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis","volume":"119","author":"Yamakawa K","year":"2019","unstructured":"Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019, 119:56-65. 10.1055\/s-0038-1676345","journal-title":"Thromb Haemost"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14812","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis","volume":"18","author":"Valeriani E","year":"2020","unstructured":"Valeriani E, Squizzato A, Gallo A, et al.. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis. J Thromb Haemost. 2020, 18:1618-25. 10.1111\/jth.14812","journal-title":"J Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the Scarlet randomized clinical trial","volume":"321","author":"Vincent JL","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, et al.. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the Scarlet randomized clinical trial. JAMA. 2019, 321:1993-2002. 10.1001\/jama.2019.5358","journal-title":"JAMA"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1379410","article-title":"Butyrylcholinesterase levels correlate with surgical site infection risk and severity after colorectal surgery: a prospective single-center study","volume":"11","author":"Verras GI","year":"2024","unstructured":"Verras GI, Mulita F. Butyrylcholinesterase levels correlate with surgical site infection risk and severity after colorectal surgery: a prospective single-center study. Front Surg. 2024, 11:1379410. 10.3389\/fsurg.2024.1379410","journal-title":"Front Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/320489-efficacy-and-safety-of-recombinant-human-soluble-thrombomodulin-in-patients-with-sepsis-induced-disseminated-intravascular-coagulation-after-emergency-surgery","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:21:59Z","timestamp":1741998119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/320489-efficacy-and-safety-of-recombinant-human-soluble-thrombomodulin-in-patients-with-sepsis-induced-disseminated-intravascular-coagulation-after-emergency-surgery"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.80589","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}